TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/10/2024
Back to search
Official data from USPTO
AVENIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
09/14/2024
Classification
Registered
Trademark type
Word
Nice classes
1, 9
Filing date
01/20/2016
Registration date
04/24/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/24/2023
Last transaction
09/14/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/01/2017
First use in commerce
06/01/2017
Drawing code
4
Owner type
03
Owner location
Pleasanton, CA
Examiner
GAYNOR, BARBARA
Law office
M60
Current location
TMO LAW OFFICE 115
Holders and representatives
Holders
Roche Molecular Systems, Inc.
Representatives
Mona Gupta Roche Diagnostics Operations, Inc.
Technical classification
Nice Classes
Class 1Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
In vitro diagnostic agentschemical control solutions for calibrating and monitoring the accuracy and function of instruments and test resultschemical additivesenzymesreagentsorganisms and proteins for use in scienceresearch and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or research purposes; reagents for the processingseparationisolationenrichmentdepletiondetectionscreeningcultivationanalysis and counting of materialin particular of chemicals and biological materialall for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer solutions and reagents for use with laboratory apparatusseparation apparatus and analysis apparatusfor scientific or research purposes; reagents for processing biological materialtissuebone marrowcellsblood and components thereof for scientific or research purposes; reagentsenzymesnucleotides for nucleic acid sequencing for scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use for analyzing cellsproteinsnucleic acidssequencing DNAgenotypinggene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotidesenzymes and buffers for nucleic acid detection in the fields of scientificpharmaceutical and medical research; nucleic acidsenzymesbuffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with DNA sequencing and genetic analysis
Class 9
software used for genotyping and gene expression microarrays for scientificpharmaceutical and medical research purposes; software used in analyzingmanaging and visualizing DNA sequencing data; software used for preparation of nucleic acids libraries; computer hardware and software for collectingstoringanalyzing and reporting biological informationfor sample tracking and managing projectslaboratory workflow and datafor use in the fields of scientificdiagnostic and clinical research and for clinical diagnostic purposes
Publications
History of USPTO decisions and trademark events.
54 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/10/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/24/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/24/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/24/2023
E815
TEAS SECTION 8 & 15 RECEIVED
04/25/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/24/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/19/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/19/2020
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/19/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/19/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/19/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/19/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/27/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/27/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/02/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/02/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/09/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/09/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
04/24/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
03/22/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/21/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
03/01/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/28/2018
EX3G
SOU EXTENSION 3 GRANTED
02/28/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
02/28/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/12/2018
EXT3
SOU EXTENSION 3 FILED
02/08/2018
EEXT
SOU TEAS EXTENSION RECEIVED
02/08/2018
IUAF
USE AMENDMENT FILED
02/07/2018
DRRR
DIVISIONAL REQUEST RECEIVED
02/07/2018
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
02/07/2018
EISU
TEAS STATEMENT OF USE RECEIVED
02/07/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
08/15/2017
EX2G
SOU EXTENSION 2 GRANTED
08/11/2017
EXT2
SOU EXTENSION 2 FILED
08/11/2017
EEXT
SOU TEAS EXTENSION RECEIVED
08/11/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
02/25/2017
EX1G
SOU EXTENSION 1 GRANTED
02/23/2017
EXT1
SOU EXTENSION 1 FILED
02/23/2017
EEXT
SOU TEAS EXTENSION RECEIVED
02/23/2017
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
08/23/2016
PUBO
PUBLISHED FOR OPPOSITION
06/28/2016
NPUB
NOTICE OF PUBLICATION
06/08/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/16/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/11/2016
CNRT
NON-FINAL ACTION MAILED
05/09/2016
CNRT
NON-FINAL ACTION WRITTEN
05/07/2016
DOCK
ASSIGNED TO EXAMINER
05/04/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/26/2016
NWAP
NEW APPLICATION ENTERED
01/23/2016
Continuous trademark protection
Get notified about every new filing that threatens AVENIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.